Long-term outcome of maintenance infliximab therapy in children with Crohnʼs disease-Reference-Cited by-同舟云学术

Long-term outcome of maintenance infliximab therapy in children with Crohnʼs disease

Published:2009-06 Issue:6 Volume:15 Page:816-822
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Hyams Jeffrey S.,Lerer Trudy,Griffiths Anne,Pfefferkorn Marian,Kugathasan Subra,Evans Jonathan,Otley Anthony,Carvalho Ryan,Mack David,Bousvaros Athos,Rosh Joel,Mamula Petar,Kay Marsha,Crandall Wallace,Oliva-Hemker Maria,Keljo David,LeLeiko Neal,Markowitz James

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference23 articles.

1. Hepatosplenic T-Cell Lymphoma in an Adolescent Patient after Immunomodulator and Biologic Therapy for Crohn Disease

2. Hepatosplenic T Cell Lymphoma Associated With Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease

3. A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

4. Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

5. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents;Saudi Journal of Gastroenterology;2024-08-30

2. Characterization of Biologic Discontinuation Among Pediatric Patients with Crohn’s Disease;Clinical Gastroenterology and Hepatology;2024-05

3. Performance of Eight Infliximab Population Pharmacokinetic Models in a Cohort of Dutch Children with Inflammatory Bowel Disease;Clinical Pharmacokinetics;2024-03-15

4. Durability of Adalimumab and Infliximab in Children With Crohn’s Disease: A Nationwide Comparison From the epi-IIRN Cohort;Inflammatory Bowel Diseases;2024-01-08

5. Early infliximab trough levels in paediatric IBD patients predict sustained remission;Therapeutic Advances in Gastroenterology;2023-12-30